Vioxx jurors are cashing in as trial advisors. “The practice of paying discharged jurors for their insights, unheard of until recently, shows a growing sophistication and coordination among mass tort lawyers as they pursue big quarry such as Merck. In addition, legal experts say, it could carry risks for the jury process as payments become more commonplace.” (via PointofLaw.com)
Vioxx jurors are cashing in as trial advisors
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Amazon and Uber set the bar that primary care is judged against
Why more medicine isn’t making us healthier
Some relationships work like medicine. Others work like a diagnosis.
Why patients stop trusting doctors who listened to them
Food allergies are treated differently, airline by airline
Staying salaried may now be the riskier bet for doctors
Doctors’ kids miss them, and the family builds its own fixes
